How to Buy indramedco Shares on Fincept?
You can buy Indraprastha Medical Corporation Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Indraprastha Medical Corporation Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Indramedco, including updates on board meetings and corporate actions.
Indraprastha Medical Corporation Limited - https://www.apollohospitals.com/delhi/
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, and sleep medicine. The company was founded in 1983 and is based in New Delhi, India.
Indraprastha Medical Corporation Limited Share Price Today
442.45
OPEN
448.90
HIGH
430.00
LOW
435.75
CLOSE
119 K
VOLUME
4,423 Cr
Market Cap
303235
Average Volume
Healthcare
Sector
NSI
Exchange
Indraprastha Medical Corporation Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: INDRAMEDCO Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
INE681B01017 |
Annual General Meeting/Dividend - Rs 4.50 Per Share |
13 Sep 2024 |
10 |
N/A |
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
INE681B01017 |
Annual General Meeting/Dividend - Rs 3 Per Share |
15 Sep 2023 |
10 |
N/A |
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
INE681B01017 |
Annual General Meeting/Dividend - Rs 2.50 Per Share |
15 Sep 2022 |
10 |
N/A |
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
INE681B01017 |
Annual General Meeting |
16 Sep 2021 |
10 |
N/A |
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
INE681B01017 |
Annual General Meeting |
17 Sep 2020 |
10 |
N/A |
NSE: INDRAMEDCO Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
INDRAMEDCO |
24 Dec 2024, 13:07:42 |
Trading Window-XBRL |
Miscellaneous |
INDRAMEDCO |
24 Dec 2024, 12:54:31 |
Trading Window |
Miscellaneous |
INDRAMEDCO |
07 Nov 2024, 17:21:17 |
Copy of Newspaper Publication |
Miscellaneous |
INDRAMEDCO |
01 Nov 2024, 13:18:22 |
General Updates |
Miscellaneous |
INDRAMEDCO |
31 Oct 2024, 21:04:50 |
Copy of Newspaper Publication |
Miscellaneous |
NSE: INDRAMEDCO Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
10 Jan 2025, 14:54:00 |
10 Jan 2025, 14:54:00 |
|
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
18 Oct 2024, 16:40:00 |
18 Oct 2024, 16:40:00 |
|
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
16 Aug 2024, 14:49:00 |
16 Aug 2024, 14:49:00 |
|
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
18 Apr 2024, 15:39:00 |
18 Apr 2024, 16:00:00 |
|
Indraprastha Medical Corporation Limited |
INDRAMEDCO |
12 Feb 2024, 12:45:00 |
12 Feb 2024, 13:15:00 |
NSE: INDRAMEDCO Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Independent Director |
16 Dec 1963 |
01 Apr 2024 |
00053597 |
Sandip Somany |
Active |
Executive Director-MD |
05 Jun 1965 |
05 Nov 2019 |
08570283 |
Shivakumar Pattabhiraman |
Active |
Chairperson Related To Promoters,Non-Executive Director |
05 Feb 1932 |
16 Mar 1988 |
00003654 |
Dr. Prathap C Reddy |
Active |
Non-Executive Director |
03 Apr 1959 |
31 Aug 2005 |
00001873 |
Suneeta Reddy |
Active |
Non-Executive Director |
08 Jul 1962 |
24 Aug 2020 |
00006285 |
Sangita Reddy |
Active |
NSE: INDRAMEDCO Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2024 . |
INDRAMEDCO |
N/A |
INE681B01017 |
Indraprastha Medical Corporation Limited |
21 Oct 2024, 11:04:21 |
INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 05-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
INDRAMEDCO |
N/A |
INE681B01017 |
Indraprastha Medical Corporation Limited |
24 Jul 2024, 11:11:18 |
INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
INDRAMEDCO |
N/A |
INE681B01017 |
Indraprastha Medical Corporation Limited |
09 May 2024, 16:15:05 |
Other business matters |
INDRAMEDCO |
N/A |
INE681B01017 |
Indraprastha Medical Corporation Limited |
05 Mar 2024, 10:49:02 |
Financial Results |
INDRAMEDCO |
N/A |
INE681B01017 |
Indraprastha Medical Corporation Limited |
27 Jan 2024, 13:36:02 |
NSE: INDRAMEDCO Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
INDRAMEDCO |
- |
INE681B01017 |
Indraprastha Medical Corporation Limited |
21 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
INDRAMEDCO |
- |
INE681B01017 |
Indraprastha Medical Corporation Limited |
24 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results/Dividend |
INDRAMEDCO |
- |
INE681B01017 |
Indraprastha Medical Corporation Limited |
09 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Other business matters |
INDRAMEDCO |
- |
INE681B01017 |
Indraprastha Medical Corporation Limited |
05 Mar 2024, 00:00:00 |
To consider other business matters |
Financial Results |
INDRAMEDCO |
- |
INE681B01017 |
Indraprastha Medical Corporation Limited |
27 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
NSE: INDRAMEDCO Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Investmentin Financial Assets | Available For Sale Securities | Goodwill And Other Intangible Assets | Other Intangible Assets | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 91,673,000.00 | 91,673,000.00 | 327,400,000.00 | 5,236,000,000.00 | 5,244,300,000.00 | 2,164,800,000.00 | 5,236,000,000.00 | 327,400,000.00 | 5,244,300,000.00 | 5,244,300,000.00 | 5,244,300,000.00 | 5,244,300,000.00 | 4,327,600,000.00 | 0.00 | 0.00 | 916,700,000.00 | 916,700,000.00 | 2,818,900,000.00 | 787,100,000.00 | 0.00 | 0.00 | 189,200,000.00 | 309,900,000.00 | 309,900,000.00 | 0.00 | 279,100,000.00 | 2,031,800,000.00 | 646,400,000.00 | 17,500,000.00 | 17,500,000.00 | 0.00 | 0.00 | 39,500,000.00 | 1,325,100,000.00 | 0.00 | 0.00 | 0.00 | 1,325,100,000.00 | 8,063,200,000.00 | 3,866,600,000.00 | 39,900,000.00 | 0.00 | 410,500,000.00 | 0.00 | 8,300,000.00 | 0.00 | 3,407,900,000.00 | 0.00 | 3,407,900,000.00 | 2,500,000.00 | 3,405,400,000.00 | 0.00 | 0.00 | 0.00 | 4,196,600,000.00 | 140,900,000.00 | 0.00 | 0.00 | 78,600,000.00 | 0.00 | 0.00 | 0.00 | 51,600,000.00 | 751,400,000.00 | 0.00 | 0.00 | 3,174,100,000.00 | 2,506,400,000.00 | 667,700,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 91,673,000.00 | 91,673,000.00 | 339,500,000.00 | 4,767,100,000.00 | 4,777,600,000.00 | 1,425,600,000.00 | 4,767,100,000.00 | 339,500,000.00 | 4,777,600,000.00 | 4,777,600,000.00 | 4,777,600,000.00 | 4,777,600,000.00 | 3,860,900,000.00 | 3,555,200,000.00 | 0.00 | 916,700,000.00 | 916,700,000.00 | 2,454,800,000.00 | 800,600,000.00 | 8,800,000.00 | 271,900,000.00 | 197,200,000.00 | 322,700,000.00 | 322,700,000.00 | 0.00 | 271,900,000.00 | 1,654,200,000.00 | 62,300,000.00 | 16,800,000.00 | 16,800,000.00 | 0.00 | 21,600,000.00 | 21,600,000.00 | 1,465,500,000.00 | 50,200,000.00 | 13,500,000.00 | 5,800,000.00 | 1,396,000,000.00 | 7,232,400,000.00 | 4,152,600,000.00 | 51,700,000.00 | 26,700,000.00 | 626,800,000.00 | 626,800,000.00 | 10,500,000.00 | 10,500,000.00 | 3,488,600,000.00 | -2,128,400,000.00 | 5,617,000,000.00 | 29,700,000.00 | 2,585,400,000.00 | 711,300,000.00 | 2,290,600,000.00 | 0.00 | 3,079,800,000.00 | 111,500,000.00 | 25,800,000.00 | 111,500,000.00 | 75,300,000.00 | 4,500,000.00 | 70,800,000.00 | 0.00 | 0.00 | 584,000,000.00 | -103,100,000.00 | 687,100,000.00 | 2,283,200,000.00 | 1,667,200,000.00 | 616,000,000.00 | 574,600,000.00 | 41,400,000.00 |
| 2024-03-31T00:00:00 | annual | 91,673,000.00 | 91,673,000.00 | 339,500,000.00 | 4,767,100,000.00 | 4,777,600,000.00 | 1,425,600,000.00 | 4,767,100,000.00 | 339,500,000.00 | 4,777,600,000.00 | 4,777,600,000.00 | 4,777,600,000.00 | 4,777,600,000.00 | 3,860,900,000.00 | 3,555,200,000.00 | 0.00 | 916,700,000.00 | 916,700,000.00 | 2,454,800,000.00 | 800,600,000.00 | 8,800,000.00 | 271,900,000.00 | 197,200,000.00 | 322,700,000.00 | 322,700,000.00 | 0.00 | 271,900,000.00 | 1,654,200,000.00 | 62,300,000.00 | 16,800,000.00 | 16,800,000.00 | 0.00 | 21,600,000.00 | 21,600,000.00 | 1,465,500,000.00 | 50,200,000.00 | 13,500,000.00 | 5,800,000.00 | 1,396,000,000.00 | 7,232,400,000.00 | 4,152,600,000.00 | 51,700,000.00 | 26,700,000.00 | 626,800,000.00 | 626,800,000.00 | 10,500,000.00 | 10,500,000.00 | 3,488,600,000.00 | -2,128,400,000.00 | 5,617,000,000.00 | 29,700,000.00 | 2,585,400,000.00 | 711,300,000.00 | 2,290,600,000.00 | 0.00 | 3,079,800,000.00 | 111,500,000.00 | 25,800,000.00 | 111,500,000.00 | 75,300,000.00 | 4,500,000.00 | 70,800,000.00 | 0.00 | 0.00 | 584,000,000.00 | -103,100,000.00 | 687,100,000.00 | 2,283,200,000.00 | 1,667,200,000.00 | 616,000,000.00 | 574,600,000.00 | 41,400,000.00 |
| 2023-09-30T00:00:00 | quarterly | 91,673,000.00 | 91,673,000.00 | 46,800,000.00 | 4,141,700,000.00 | 4,147,500,000.00 | 954,600,000.00 | 4,141,700,000.00 | 46,800,000.00 | 4,147,500,000.00 | 4,147,500,000.00 | 4,147,500,000.00 | 4,147,500,000.00 | 3,230,800,000.00 | 0.00 | 0.00 | 916,700,000.00 | 916,700,000.00 | 2,528,100,000.00 | 458,000,000.00 | 0.00 | 0.00 | 181,500,000.00 | 31,000,000.00 | 31,000,000.00 | 0.00 | 236,600,000.00 | 2,070,100,000.00 | 483,800,000.00 | 15,800,000.00 | 15,800,000.00 | 0.00 | 0.00 | 48,000,000.00 | 1,421,100,000.00 | 0.00 | 0.00 | 63,200,000.00 | 1,357,900,000.00 | 6,675,600,000.00 | 3,650,900,000.00 | 22,000,000.00 | 0.00 | 509,600,000.00 | 0.00 | 5,800,000.00 | 0.00 | 3,113,500,000.00 | 0.00 | 3,113,500,000.00 | 314,800,000.00 | 2,798,700,000.00 | 0.00 | 0.00 | 0.00 | 3,024,700,000.00 | 124,500,000.00 | 0.00 | 0.00 | 79,600,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 683,800,000.00 | 0.00 | 0.00 | 2,136,800,000.00 | 1,756,000,000.00 | 380,800,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 91,673,000.00 | 91,673,000.00 | 24,800,000.00 | 3,784,900,000.00 | 3,794,500,000.00 | 934,500,000.00 | 3,784,900,000.00 | 24,800,000.00 | 3,794,500,000.00 | 3,794,500,000.00 | 3,794,500,000.00 | 3,794,500,000.00 | 2,877,800,000.00 | 2,590,600,000.00 | 0.00 | 916,700,000.00 | 916,700,000.00 | 1,756,900,000.00 | 460,600,000.00 | 16,600,000.00 | 244,200,000.00 | 199,800,000.00 | 0.00 | 0.00 | 0.00 | 244,200,000.00 | 1,296,300,000.00 | 59,600,000.00 | 24,800,000.00 | 24,800,000.00 | 0.00 | 94,900,000.00 | 94,900,000.00 | 1,047,600,000.00 | 7,600,000.00 | 14,000,000.00 | 44,200,000.00 | 981,800,000.00 | 5,551,400,000.00 | 3,320,600,000.00 | 70,600,000.00 | 23,800,000.00 | 474,200,000.00 | 474,200,000.00 | 9,600,000.00 | 9,600,000.00 | 2,813,000,000.00 | -2,158,600,000.00 | 4,971,600,000.00 | 72,100,000.00 | 2,094,500,000.00 | 760,200,000.00 | 2,044,800,000.00 | 0.00 | 2,230,800,000.00 | 108,600,000.00 | 25,400,000.00 | 108,600,000.00 | 84,500,000.00 | 3,700,000.00 | 80,800,000.00 | 0.00 | 0.00 | 682,400,000.00 | -85,300,000.00 | 767,700,000.00 | 1,329,900,000.00 | 807,300,000.00 | 522,600,000.00 | 512,300,000.00 | 10,300,000.00 |
| 2023-03-31T00:00:00 | annual | 91,673,000.00 | 91,673,000.00 | 24,800,000.00 | 3,784,900,000.00 | 3,794,500,000.00 | 934,500,000.00 | 3,784,900,000.00 | 24,800,000.00 | 3,794,500,000.00 | 3,794,500,000.00 | 3,794,500,000.00 | 3,794,500,000.00 | 2,877,800,000.00 | 2,590,600,000.00 | 0.00 | 916,700,000.00 | 916,700,000.00 | 1,756,900,000.00 | 460,600,000.00 | 16,600,000.00 | 244,200,000.00 | 199,800,000.00 | 0.00 | 0.00 | 0.00 | 244,200,000.00 | 1,296,300,000.00 | 59,600,000.00 | 24,800,000.00 | 24,800,000.00 | 0.00 | 94,900,000.00 | 94,900,000.00 | 1,047,600,000.00 | 7,600,000.00 | 14,000,000.00 | 44,200,000.00 | 981,800,000.00 | 5,551,400,000.00 | 3,320,600,000.00 | 70,600,000.00 | 23,800,000.00 | 474,200,000.00 | 474,200,000.00 | 9,600,000.00 | 9,600,000.00 | 2,813,000,000.00 | -2,158,600,000.00 | 4,971,600,000.00 | 72,100,000.00 | 2,094,500,000.00 | 760,200,000.00 | 2,044,800,000.00 | 0.00 | 2,230,800,000.00 | 108,600,000.00 | 25,400,000.00 | 108,600,000.00 | 84,500,000.00 | 3,700,000.00 | 80,800,000.00 | 0.00 | 0.00 | 682,400,000.00 | -85,300,000.00 | 767,700,000.00 | 1,329,900,000.00 | 807,300,000.00 | 522,600,000.00 | 512,300,000.00 | 10,300,000.00 |
| 2022-03-31T00:00:00 | annual | 91,673,000.00 | 91,673,000.00 | 53,100,000.00 | 3,237,300,000.00 | 3,254,400,000.00 | 639,300,000.00 | 3,237,300,000.00 | 53,100,000.00 | 3,254,400,000.00 | 3,254,400,000.00 | 3,254,400,000.00 | 3,254,400,000.00 | 2,337,700,000.00 | 1,958,300,000.00 | 0.00 | 916,700,000.00 | 916,700,000.00 | 1,362,700,000.00 | 427,700,000.00 | 17,900,000.00 | 153,100,000.00 | 231,900,000.00 | 24,800,000.00 | 24,800,000.00 | 0.00 | 153,100,000.00 | 935,000,000.00 | 41,300,000.00 | 28,300,000.00 | 28,300,000.00 | 0.00 | 8,700,000.00 | 8,700,000.00 | 788,000,000.00 | 7,300,000.00 | 13,200,000.00 | 0.00 | 767,500,000.00 | 4,617,100,000.00 | 3,042,800,000.00 | 25,800,000.00 | 34,400,000.00 | 230,100,000.00 | 230,100,000.00 | 17,100,000.00 | 17,100,000.00 | 2,761,100,000.00 | -1,865,300,000.00 | 4,626,400,000.00 | 9,600,000.00 | 1,944,800,000.00 | 658,600,000.00 | 2,013,400,000.00 | 0.00 | 1,574,300,000.00 | 42,000,000.00 | 24,400,000.00 | 94,100,000.00 | 99,900,000.00 | 6,100,000.00 | 93,800,000.00 | 0.00 | 168,700,000.00 | 433,500,000.00 | -79,300,000.00 | 512,800,000.00 | 707,900,000.00 | 290,500,000.00 | 417,400,000.00 | 404,400,000.00 | 13,000,000.00 |
| 2021-03-31T00:00:00 | annual | 91,673,000.00 | 91,673,000.00 | 78,100,000.00 | 2,693,700,000.00 | 2,727,500,000.00 | 255,300,000.00 | 2,693,700,000.00 | 78,100,000.00 | 2,727,500,000.00 | 2,727,500,000.00 | 2,727,500,000.00 | 2,727,500,000.00 | 1,810,830,000.00 | 1,372,100,000.00 | 0.00 | 916,700,000.00 | 916,700,000.00 | 1,592,000,000.00 | 433,000,000.00 | 0.00 | 137,630,000.00 | 222,600,000.00 | 53,000,000.00 | 53,000,000.00 | 0.00 | 137,600,000.00 | 1,159,000,000.00 | 54,900,000.00 | 25,100,000.00 | 25,100,000.00 | 0.00 | 84,100,000.00 | 84,080,000.00 | 949,400,000.00 | 16,100,000.00 | 15,800,000.00 | 0.00 | 917,500,000.00 | 4,319,500,000.00 | 2,905,200,000.00 | 20,270,000.00 | 36,000,000.00 | 0.00 | 0.00 | 33,800,000.00 | 33,800,000.00 | 2,835,000,000.00 | -1,668,900,000.00 | 4,503,900,000.00 | 35,500,000.00 | 1,887,700,000.00 | 591,500,000.00 | 1,989,200,000.00 | 0.00 | 1,414,300,000.00 | 72,200,000.00 | 26,000,000.00 | 107,400,000.00 | 87,400,000.00 | 6,000,000.00 | 81,400,000.00 | 0.00 | 149,000,000.00 | 673,900,000.00 | -75,300,000.00 | 749,200,000.00 | 296,100,000.00 | 46,900,000.00 | 249,200,000.00 | 240,800,000.00 | 8,400,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 39,750,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,510,000.00 | 63,760,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: INDRAMEDCO Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Capital Expenditure | End Cash Position | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Payments | Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Payments | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Net PPE Purchase And Sale | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Interest Paid Cfo | Change In Working Capital | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Depreciation And Amortization | Depreciation | Gain Loss On Investment Securities | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 1,307,600,000.00 | 0.00 | 0.00 | -693,900,000.00 | 616,000,000.00 | 522,600,000.00 | 93,400,000.00 | -323,800,000.00 | -10,500,000.00 | -275,400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,584,300,000.00 | 0.00 | 123,100,000.00 | -1,013,500,000.00 | -693,900,000.00 | -693,900,000.00 | 2,001,500,000.00 | -468,300,000.00 | -100,000.00 | 554,600,000.00 | 406,700,000.00 | 9,200,000.00 | 138,700,000.00 | -158,300,000.00 | 400,800,000.00 | 400,800,000.00 | 11,700,000.00 | 0.00 | 1,661,100,000.00 |
| 2023-03-31T00:00:00 | annual | 998,900,000.00 | 0.00 | 0.00 | -445,800,000.00 | 522,600,000.00 | 417,400,000.00 | 105,200,000.00 | -260,400,000.00 | -3,700,000.00 | -228,400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,079,100,000.00 | 0.00 | 89,400,000.00 | -722,700,000.00 | -445,800,000.00 | -445,800,000.00 | 1,444,700,000.00 | -98,500,000.00 | -900,000.00 | 66,600,000.00 | 286,100,000.00 | 15,400,000.00 | -234,900,000.00 | -95,700,000.00 | 392,700,000.00 | 392,700,000.00 | 8,700,000.00 | 0.00 | 1,171,800,000.00 |
| 2022-03-31T00:00:00 | annual | 648,200,000.00 | 0.00 | 0.00 | -294,800,000.00 | 417,400,000.00 | 249,200,000.00 | 168,200,000.00 | -33,700,000.00 | -6,000,000.00 | -2,600,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -741,100,000.00 | -241,000,000.00 | 24,800,000.00 | -471,100,000.00 | -294,800,000.00 | -294,800,000.00 | 943,000,000.00 | -195,100,000.00 | -100,000.00 | -34,500,000.00 | -281,500,000.00 | -12,500,000.00 | 259,500,000.00 | -25,100,000.00 | 349,400,000.00 | 349,400,000.00 | 57,700,000.00 | 0.00 | 790,700,000.00 |
| 2021-03-31T00:00:00 | annual | 58,500,000.00 | 0.00 | 0.00 | -209,600,000.00 | 249,200,000.00 | 203,300,000.00 | 45,900,000.00 | -31,400,000.00 | -8,100,000.00 | -2,400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -190,800,000.00 | 10,800,000.00 | 8,000,000.00 | 10,800,000.00 | -209,600,000.00 | -209,600,000.00 | 268,100,000.00 | -93,700,000.00 | 0.00 | -22,700,000.00 | -141,300,000.00 | 33,300,000.00 | 85,300,000.00 | 1,300,000.00 | 333,200,000.00 | 333,200,000.00 | 7,100,000.00 | 7,120,000.00 | 42,900,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | -210,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -178,630,000.00 | -210,000,000.00 | 0.00 | 0.00 | 0.00 | -210,000,000.00 | -210,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,140,000.00 | 0.00 |
NSE: INDRAMEDCO Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -0.30 | 0.00 | 208.42 | -1.17 | -1.17 | 123.96 | 40.08 | 790.59 | 207.25 | 167.17 | 12.83 | 1.06 | 16.89 | 124.83 | 123.96 | 1,049.61 | 2.35 | 9.17 | 9.17 | 0.00 | 0.00 | 123.96 | 123.96 | 0.00 | 123.96 | 123.96 | 123.96 | 42.15 | 166.11 | 16.89 | -1.17 | 1.17 | 12.83 | 3.00 | 1.06 | 16.89 | 154.45 | 259.02 | 138.15 | 40.08 | 0.62 | 39.46 | 115.97 | 104.22 | 11.75 | 2.35 | 413.47 | 790.59 | 1,204.06 | 1,204.06 |
| 2023-03-31T00:00:00 | annual | -0.23 | 0.00 | 157.78 | -0.87 | -0.87 | 86.15 | 39.27 | 720.30 | 156.91 | 117.64 | 5.75 | 0.46 | 10.03 | 86.79 | 86.15 | 952.65 | 2.19 | 9.17 | 9.17 | 0.00 | 0.00 | 86.15 | 86.15 | 0.00 | 86.15 | 86.15 | 86.15 | 31.03 | 117.18 | 10.03 | -0.87 | 0.87 | 5.75 | 3.82 | 0.46 | 10.03 | 112.30 | 232.35 | 125.29 | 39.27 | 1.43 | 37.84 | 96.96 | 87.27 | 9.69 | 2.19 | 344.65 | 720.30 | 1,064.95 | 1,064.95 |
| 2022-03-31T00:00:00 | annual | -1.49 | 0.00 | 120.39 | -5.77 | -5.77 | 58.62 | 34.94 | 597.16 | 114.62 | 79.68 | -0.29 | 0.61 | 3.12 | 62.90 | 58.62 | 777.01 | 1.86 | 9.17 | 9.17 | 0.00 | 0.00 | 58.62 | 58.62 | 0.00 | 58.62 | 58.62 | 58.62 | 20.45 | 79.07 | 3.12 | -5.77 | 5.77 | -0.29 | 2.80 | 0.61 | 3.12 | 85.13 | 179.85 | 107.18 | 34.94 | 0.00 | 34.94 | 60.21 | 53.35 | 6.86 | 1.86 | 264.98 | 597.16 | 862.14 | 862.14 |
| 2021-03-31T00:00:00 | annual | -0.21 | 0.00 | 38.32 | -0.71 | -0.71 | 2.33 | 33.32 | 446.57 | 37.61 | 4.29 | -2.66 | 0.00 | 0.68 | 2.83 | 2.33 | 588.38 | 2.01 | 9.17 | 9.17 | 0.00 | 0.00 | 2.33 | 2.33 | 0.00 | 2.33 | 2.33 | 2.33 | 1.96 | 4.29 | 0.68 | -0.71 | 0.71 | -2.66 | 3.34 | 0.00 | 0.68 | 7.66 | 141.81 | 91.28 | 33.32 | 0.00 | 33.32 | 32.09 | 26.44 | 5.65 | 2.01 | 149.47 | 446.57 | 596.04 | 596.04 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
6/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
16.13
P/E
29.910109
P/B
8.424573
Dividend Yield
0.92%
Market Cap
4,422.76 Cr.
Face Value
57.267
Book Value
57.267
ROE
11.21%
EBITDA Growth
223.87 Cr.
Debt/Equity
6.243
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of indramedco?
The market capitalization of Indraprastha Medical Corporation Limited is ₹4,423 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Indraprastha Medical Corporation Limited?
The PE and PB ratios of Indraprastha Medical Corporation Limited are Not Available and 8.424573 respectively as of 05 Feb 2025.
What is the 52 Week High of Indraprastha Medical Corporation Limited?
The 52-week high of Indraprastha Medical Corporation Limited is ₹529.9 as of 05 Feb 2025.
What is the 52 Week Low of Indraprastha Medical Corporation Limited?
The 52-week low of Indraprastha Medical Corporation Limited is ₹154.5 as of 05 Feb 2025.
What are the earnings per share (EPS) for Indraprastha Medical Corporation Limited?
The Earnings Per Share (EPS) of Indraprastha Medical Corporation Limited is ₹16.13 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Indraprastha Medical Corporation Limited?
The Return on Equity (ROE) of Indraprastha Medical Corporation Limited is 11.21% as per the most recent financial year data. Explore more on Fincept.